Form 4: Takeda Pharmaceutical Co Executive Sells Shares
Insider Transaction (Form 4)
Lauren Rusckowski Duprey, Chief Transformation Officer of Takeda Pharmaceutical Co Ltd, sold 34,535 shares of common stock on September 14, 2026 for $18.54 per share.
Summary
- Open-market sale: disposed of 34,535 American Depositary Shares at $18.54 ($640,279) on September 14, 2026; holds 191,522 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $640,279 of stock on the open market.
Insider Transactions
Lauren Rusckowski Duprey — Officer (Chief Transformation Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-14 | Open-market sale | American Depositary Shares | 34,535 | $19 | $640.3K | 191,522 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-14 | Open-market sale (34,535 shares) |
Keywords
insider transaction, Form 4, TAK, TAKEDA PHARMACEUTICAL CO LTD, bearish, Lauren Rusckowski Duprey
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.